Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria

BACKGROUND: Artemisinin-based combination therapy (ACT) is recommended as a means of prolonging the effectiveness of first-line malaria treatment regimens. Different brands of mefloquine (MQ) have been reported to be non-bioequivalent; this could result in sub-therapeutic levels of mefloquine with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutman, Julie, Green, Michael, Durand, Salomon, Rojas, Ofelia Villalva, Ganguly, Babita, Quezada, Wilmer Marquiño, Utz, Gregory C, Slutsker, Laurence, Ruebush, Trenton K, Bacon, David J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674465/
https://www.ncbi.nlm.nih.gov/pubmed/19358697
http://dx.doi.org/10.1186/1475-2875-8-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674465/
https://www.ncbi.nlm.nih.gov/pubmed/19358697
http://dx.doi.org/10.1186/1475-2875-8-58

Ejemplares similares